Eastling Thomas Wilson bought GYRE
May 4, 2026 · Form 4 insider transaction
Eastling Thomas Wilson bought 47,530 shares of Gyre Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
47,530
Price
$0.00
Total value
N/A
InsiderEastling Thomas Wilson
RoleOfficer
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateMay 4, 2026
Filing dateMay 6, 2026
Shares owned after47,530
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This option is fully vested.